STOCK TITAN

Syra Health reported $7.2M in revenue and a $896K net loss for fiscal 2025. See the full SYRA financial statements: income statement, balance sheet, cash flow and ratios, each column linked to its SEC filing.

Syra Health, in Partnership with HealthSync, Selected for CMS ACCESS Model, Advancing Long-Term Growth Strategy

(Very High)
(Very Positive)
Tags
partnership

Syra Health (SYRA) announced that, in partnership with HealthSync, it has been accepted into the CMS ACCESS (Advancing Chronic Care with Effective, Scalable Solutions) model, a federal program focused on improving chronic and behavioral healthcare delivery and reimbursement for Original Medicare beneficiaries.

Under the collaboration, Syra Health and HealthSync plan to engage healthcare providers and support patient referrals into ACCESS and ACCESS‑aligned programs, using Syra Health’s digital behavioral health platform, Syrenity, as the enabling solution. Syrenity has shown reductions in depression and anxiety symptoms and improvements in overall well‑being in a clinical research study conducted by Indiana University for individuals with access to the platform compared with those without access. The company’s CEO describes ACCESS participation as a potential durable, ten‑year revenue engine that may enable scaled deployment of Syrenity, where prescribers can be reimbursed for patient referrals and patients receive continuous, affordable, prevention‑first behavioral health support. The partnership with HealthSync remains subject to negotiation and the execution of a definitive agreement.

Loading...
Loading translation...

Positive

  • Accepted into CMS ACCESS model, enabling participation in a federal program aimed at scalable, value-based behavioral healthcare for Original Medicare beneficiaries.
  • Syrenity clinical study by Indiana University showed reduced depression and anxiety symptoms and better overall well-being for users compared with non-users.

Negative

  • The partnership with HealthSync is not yet final and remains subject to negotiation and execution of a definitive agreement.
  • Management only characterizes ACCESS participation as a potential “ten-year revenue engine”, with no quantified revenue projections or financial metrics disclosed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

CARMEL, Ind., Sept. 3, 2026 /PRNewswire/ -- Syra Health Corp. (OTCQB: SYRA) ("Syra Health" or the "Company"), an integrated healthcare solutions company powering better health outcomes through prevention-focused, accessible, and affordable solutions, announced today that, in partnership with HealthSync, it has been accepted into the CMS (Centers for Medicare & Medicaid) ACCESS (Advancing Chronic Care with Effective, Scalable Solutions) model. Inclusion in the federal program reinforces the Company's commitment to helping providers improve behavioral health outcomes while making solutions more affordable for patients.

Syra Health, Powering Better Health

As part of the collaboration, Syra Health and HealthSync will work together to engage healthcare providers and support patient referrals into ACCESS and ACCESS-aligned programs, using Syrenity as the enabling behavioral health solution. Together, the companies aim to expand access to coordinated behavioral health services and improve outcomes for individuals enrolled in Original Medicare. Syra Health's partnership with HealthSync remains subject to negotiation and the execution of a definitive agreement between the parties.

Syrenity is Syra Health's award-winning digital mental and behavioral health solution designed to improve behavioral and mental health outcomes. In a clinical research study conducted by Indiana University, Syrenity demonstrated reductions in depression and anxiety symptoms and improvements in overall well-being for those with access to Syrenity when compared to those without access.

"Inclusion in the CMS ACCESS model program represents what we believe can become a durable, ten-year revenue engine for Syra Health," said Greg Alexander, CEO of Syra Health. "We expect this federal government model to enable scaled deployment of Syrenity across behavioral health populations, where prescribers can be reimbursed for referring patients and patients gain continuous, affordable access to prevention-first digital behavioral health support."

The CMS ACCESS model is designed to advance innovative approaches to healthcare delivery and reimbursement, with an emphasis on improving patient outcomes, expanding access, and accelerating value-based care. Syra Health's participation aligns with its broader mission to deliver prevention-focused, affordable, and accessible healthcare solutions that improve outcomes across diverse populations.

About Syra Health

Syra Health is an integrated healthcare solutions company serving government and commercial healthcare organizations with innovative solutions designed to improve health outcomes. We specialize in healthcare prevention, expanding access, and delivering affordable solutions. Our healthcare analytics provide proactive, actionable insights and data-driven intelligence, and our HIPAA-compliant, fully accessible, and award-winning digital health solutions enable measurable health outcomes in highly regulated healthcare environments. Through training and education, we help healthcare organizations reduce costs and deliver consistent, high-quality care. Discover our healthcare solutions at www.syrahealth.com and follow the Company on LinkedIn.

About HealthSync

To empower healthcare professionals with cutting-edge, data-driven insights and real-time analytics, enhancing clinical decision-making and improving patient outcomes through innovative technology, seamless integration, and unwavering support. For more information, please visit www.healthsync.live.

Forward-Looking Statements

 Statements in this press release about future expectations, plans, and prospects, as well as any other statements regarding matters that are not historical facts, may constitute "forward-looking statements." These statements include but are not limited to, statements relating to the expected use of proceeds, the Company's operations and business strategy, the risk that the Company will not be able to enter into a definitive agreement with HealthSync on favorable terms, or at all, and the Company's expected financial results. The words "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "should," "target," "will," "would" and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. The forward-looking statements contained in this press release are based on management's current expectations and are subject to substantial risks, uncertainty, and changes in circumstances. Investors should read the risk factors set forth in our Form 10-K for the year ended December 31, 2025, and other periodic reports filed with the Securities and Exchange Commission. Any forward-looking statements contained in this press release speak only as of the date hereof, and, except as required by federal securities laws, the Company specifically disclaims any obligation to update any forward-looking statements, whether as a result of new information, future events, or otherwise.

Contact

Christine Drury

IR/PR
Syra Health

christined@syrahealth.com

317-385-9227

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/syra-health-in-partnership-with-healthsync-selected-for-cms-access-model-advancing-long-term-growth-strategy-302868280.html

SOURCE Syra Health

FAQ

What did Syra Health (SYRA) announce about the CMS ACCESS model?

Syra Health announced that, in partnership with HealthSync, it has been accepted into the CMS ACCESS model, a federal program focused on advancing scalable chronic and behavioral care solutions for Original Medicare beneficiaries, with Syrenity serving as the enabling behavioral health platform.

How will Syra Health and HealthSync work together under the CMS ACCESS model for SYRA?

Syra Health and HealthSync plan to engage healthcare providers and support patient referrals into ACCESS and ACCESS-aligned programs, using Syrenity as the behavioral health solution. The collaboration is intended to expand access to coordinated behavioral health services and improve outcomes for individuals in Original Medicare.

What is Syrenity and what clinical results has Syra Health (SYRA) reported?

Syrenity is Syra Health’s digital mental and behavioral health solution. In a clinical research study conducted by Indiana University, Syrenity users showed reductions in depression and anxiety symptoms and improvements in overall well-being compared with individuals who did not have access to the platform.

How does CMS ACCESS participation support Syra Health’s long-term growth strategy for SYRA?

Syra Health’s CEO describes inclusion in the CMS ACCESS model as what the company believes can become a durable, ten-year revenue engine, enabling scaled deployment of Syrenity, reimbursement for prescribers who refer patients, and continuous, affordable, prevention-first digital behavioral health support for Medicare populations.

Is the partnership between Syra Health (SYRA) and HealthSync already finalized?

No. The partnership between Syra Health and HealthSync remains subject to negotiation and the execution of a definitive agreement between the parties, meaning the collaboration framework is not yet contractually finalized even though they have been accepted into the CMS ACCESS model.

What goals does the CMS ACCESS model aim to achieve for Syra Health (SYRA) and other participants?

The CMS ACCESS model is designed to advance innovative approaches to healthcare delivery and reimbursement, emphasizing improved patient outcomes, expanded access, and accelerated value-based care. Syra Health’s participation aligns with its mission to deliver prevention-focused, affordable, and accessible healthcare solutions across diverse populations.